174 related articles for article (PubMed ID: 2118053)
1. Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro.
Li S; Zhang XY; Chen XT; Fan DM; Tan LS; Pan HZ; Huang LQ
Chin Med J (Engl); 1990 May; 103(5):376-9. PubMed ID: 2118053
[TBL] [Abstract][Full Text] [Related]
2. Selective cytotoxicity against human tumor cells by an anti-gastric cancer monoclonal antibody-mitomycin C conjugate.
Li S; Zhang XY; Chen XT; Zhang SY; Chen LJ; Zhang JL
Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):367-70. PubMed ID: 2129522
[TBL] [Abstract][Full Text] [Related]
3. Specific targeting of mitomycin C to tumors by anti-gastric cancer monoclonal antibody.
Li S; Zhang XY; Chen XT; Fan DM; Zhan SY; Chen LJ; Shu YH; Zhang JL
Chin Med J (Engl); 1991 May; 104(5):358-62. PubMed ID: 1908761
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
5. [Specific targeting of mitomycin C to tumors with the use of anti-gastric cancer monoclonal antibody].
Li S
Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):363-6, 26. PubMed ID: 2171725
[TBL] [Abstract][Full Text] [Related]
6. [The selective cytotoxicity of monoclonal antibody conjugated with mitomycin C on human gastric cancer cells].
Liang YY; Wang NQ; Li N; Cui JQ; Dong ZW
Yao Xue Xue Bao; 1989; 24(11):801-6. PubMed ID: 2618675
[TBL] [Abstract][Full Text] [Related]
7. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and cytotoxicity of McAb-HSA-MTX conjugates].
Yin Z
Zhonghua Yi Xue Za Zhi; 1990 Oct; 70(10):556-9, 40. PubMed ID: 2176564
[TBL] [Abstract][Full Text] [Related]
9. [Selective cytotoxicity of antibody-ricin-A-chain conjugate for human tumor B cells. II. Comparison of activity of immunotoxins conjugated with poly- and monoclonal antibodies].
Tonevitskiĭ AG; Zhukova OS; Rakhmanova VA; Arsen'eva EL; Bogacheva GT
Mol Biol (Mosk); 1988; 22(4):911-6. PubMed ID: 3141780
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor activity of daunomycin conjugated with antigastric cancer monoclonal antibody MGb2.
Li S; Zhang XY; Qiao TD; Chen XT; Zhang SY; Chen LJ
Oncol Res; 1992; 4(11-12):447-53. PubMed ID: 1299375
[TBL] [Abstract][Full Text] [Related]
11. Preparation of antigastric cancer monoclonal antibody MGb2-mitomycin C conjugate with improved antitumor activity.
Li S; Zhang XY; Zhang SY; Chen XT; Chen LJ; Shu YH; Zhang JL; Fan DM
Bioconjug Chem; 1990; 1(4):245-50. PubMed ID: 2129014
[TBL] [Abstract][Full Text] [Related]
12. Conjugates of mitomycin C with the immunoglobulin M monomer fragment of a monoclonal anti-MM46 immunoglobulin M antibody with or without serum albumin as intermediary.
Umemoto N; Kato Y; Takeda Y; Saito M; Hara T; Seto M; Takahashi T
J Appl Biochem; 1984; 6(5-6):297-307. PubMed ID: 6443109
[TBL] [Abstract][Full Text] [Related]
13. Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb.
Cogliati T; Brusa P; Canevari S; Caldera M; Mezzanzanica D; Dosio F; Cattel L; Colnaghi MI
Anticancer Res; 1991; 11(1):417-21. PubMed ID: 2018380
[TBL] [Abstract][Full Text] [Related]
14. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
Dillman RO; Johnson DE; Ogden J; Beidler D
Mol Biother; 1989; 1(5):250-5. PubMed ID: 2515870
[TBL] [Abstract][Full Text] [Related]
15. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
18. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
Hara H; Luo Y; Haruta Y; Seon BK
Cancer Res; 1988 Aug; 48(16):4673-80. PubMed ID: 2969282
[TBL] [Abstract][Full Text] [Related]
19. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
Pietersz GA; Kanellos J; McKenzie IF
Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
[TBL] [Abstract][Full Text] [Related]
20. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
